GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (FRA:BIO) » Definitions » E10

Biotest AG (FRA:BIO) E10 : €0.25 (As of Mar. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.740. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.25 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biotest AG was -52.40% per year. The lowest was -52.40% per year. And the median was -52.40% per year.

As of today (2024-06-22), Biotest AG's current stock price is €40.60. Biotest AG's E10 for the quarter that ended in Mar. 2024 was €0.25. Biotest AG's Shiller PE Ratio of today is 162.40.

During the past 13 years, the highest Shiller PE Ratio of Biotest AG was 1075.00. The lowest was 27.09. And the median was 69.47.


Biotest AG E10 Historical Data

The historical data trend for Biotest AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG E10 Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 - 0.07 -0.10 0.19

Biotest AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.15 0.11 0.19 0.25

Competitive Comparison of Biotest AG's E10

For the Biotechnology subindustry, Biotest AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotest AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotest AG's Shiller PE Ratio falls into.



Biotest AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.74/125.0381*125.0381
=0.740

Current CPI (Mar. 2024) = 125.0381.

Biotest AG Quarterly Data

per share eps CPI Adj_EPS
201406 0.223 99.543 0.280
201409 0.137 99.823 0.172
201412 -0.013 99.543 -0.016
201503 0.037 99.717 0.046
201506 -0.090 100.417 -0.112
201509 -2.170 100.417 -2.702
201512 0.120 99.717 0.150
201603 0.050 100.017 0.063
201606 0.140 100.717 0.174
201609 -0.230 101.017 -0.285
201612 -1.130 101.217 -1.396
201703 -0.620 101.417 -0.764
201706 0.150 102.117 0.184
201709 -0.120 102.717 -0.146
201712 0.465 102.617 0.567
201803 0.670 102.917 0.814
201806 4.010 104.017 4.820
201809 0.130 104.718 0.155
201812 -0.243 104.217 -0.292
201903 -0.040 104.217 -0.048
201906 0.070 105.718 0.083
201909 -0.130 106.018 -0.153
201912 -0.056 105.818 -0.066
202003 -0.280 105.718 -0.331
202006 -0.160 106.618 -0.188
202009 -0.390 105.818 -0.461
202012 0.000 105.518 0.000
202103 -0.370 107.518 -0.430
202106 -0.110 108.486 -0.127
202109 -0.260 109.435 -0.297
202112 -0.897 110.384 -1.016
202203 -0.130 113.968 -0.143
202206 -0.390 115.760 -0.421
202209 -0.370 118.818 -0.389
202212 0.053 119.345 0.056
202303 -0.530 122.402 -0.541
202306 0.550 123.140 0.558
202309 2.891 124.195 2.911
202312 0.975 123.773 0.985
202403 0.740 125.038 0.740

Add all the adjusted EPS together and divide 10 will get our e10.


Biotest AG  (FRA:BIO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biotest AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=40.60/0.25
=162.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biotest AG was 1075.00. The lowest was 27.09. And the median was 69.47.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biotest AG E10 Related Terms

Thank you for viewing the detailed overview of Biotest AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG (FRA:BIO) Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.

Biotest AG (FRA:BIO) Headlines